Evidence map›Paper›PMID 36745223›Full record

ArticleJournal of cancer research and clinical oncology2023

Carbon ion irradiation induces DNA damage in melanoma and optimizes the tumor microenvironment based on the cGAS-STING pathway.

Yanan Guo, Rong Shen, Fang Wang, Yutong Wang, Peng Xia, Rile Wu, Xiangwen Liu, Weichun Ye, Yingxia Tian, Degui Wang

Open access · greenAbstract read
In one paragraph

Article in Journal of cancer research and clinical oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Elucidating DNA Damage-Dependent Immune System Activation.International journal of molecular sciences · 2025
    Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Carbon Ion Irradiation Activates Anti-Cancer Immunity.International journal of molecular sciences · 2024
    Review
  16. Review
  17. Review
  18. Review
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Yanan Guo *School of Basic Medical Sciences, Lanzhou University, Lanzhou, 73000, Gansu, China.
Rong Shen *School of Basic Medical Sciences, Lanzhou University, Lanzhou, 73000, Gansu, China.
Fang Wang *School of Basic Medical Sciences, Lanzhou University, Lanzhou, 73000, Gansu, China.
Yutong WangSchool of Basic Medical Sciences, Lanzhou University, Lanzhou, 73000, Gansu, China.
Peng XiaSchool of Basic Medical Sciences, Lanzhou University, Lanzhou, 73000, Gansu, China.
Rile WuSchool of Basic Medical Sciences, Lanzhou University, Lanzhou, 73000, Gansu, China.
Xiangwen LiuSchool of Basic Medical Sciences, Lanzhou University, Lanzhou, 73000, Gansu, China.
Weichun YeState Key Laboratory of Applied Organic Chemistry and Department of Chemistry, Lanzhou University, Lanzhou, 730000, China. yewch@lzu.edu.cn.
Yingxia TianDepartment of Internal Medicine, Gansu Provincial Academic Institute for Medical Research, Lanzhou, 730050, China. tianyxlz@163.com.
Degui WangSchool of Basic Medical Sciences, Lanzhou University, Lanzhou, 73000, Gansu, China. wangdegui@lzu.edu.cn.
Lanzhou University · CNGansu Provincial Cancer Hospital Gansu Provincial Academic Instiute for Medical Research · CN

Funding

Fundamental Research Funds for the Central Universities lzujbky-2022-12National Natural Science Foundation of China 81772907National Natural Science Foundation of China 82203630
6 · The paper itself

Abstract

purposesIncreased number of studies reveal the crucial role of the Cyclic GMP-AMP synthase/stimulator of interferon genes (cGAS/STING) pathway in anti-tumor immunity. In this study, we aim to explore the effect of cGAS/STING on tumor immune microenvironment of melanoma after carbon ion radiotherapy (CIRT) and the underlying mechanism.

methodsC57BL/6 mouse tumor models were used to evaluate the efficacy of different treatments (X-ray, carbon ion, PD-L1 inhibitor and combination therapies) on tumor growth and process. Mass cytometry was performed to assess tumor-infiltrating lymphocytes (TILs). DNA damage response (DDR) and cGAS/STING pathway were investigated by immunofluorescence-co-localization assays, γ-H2AX, P53-binding protein 1 (53BP1), Breast Cancer 1 (BRCA1), and cGAS measurements.

resultsCarbon ion irradiation caused more DNA damages and cGAS-STING pathway activation compared with X-ray irradiation, and the former slowed the melanoma growth in syngeneic model. Although X-ray irradiation is not sensitive for melanoma treatment, carbon ion irradiation showed a significant anti-tumor effect for melanoma treatment. TILs analysis revealed that CIRT boosted the infiltration of natural killer (NK), CD4

conclusionsOur findings showed that CIRT displayed biological effects by increasing DNA damages of tumor cells and improving immunity in melanoma, which indicated that CIRT might be a potential synergetic treatment for radiotherapy and radioimmunotherapy in melanoma patients. Our works put forward a new insight to provide an effective strategy for melanoma therapy. These findings may help in the design of strategies on melanoma in clinical studies.

Indexed as

Heavy Ion RadiotherapyMelanomaAnimalsCD8-Positive T-LymphocytesDNA DamageImmune Checkpoint InhibitorsMiceMice, Inbred C57BLNucleotidyltransferasesTumor MicroenvironmentImmune Checkpoint InhibitorsNucleotidyltransferasesCarbon ioncGASImmunotherapyPD-L1 inhibitorSTINGX-ray

Identifiers

PMID36745223
PMCPMC11798016
OpenAlexW4319293523

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.